Hila Karah

CIK: 0001668116

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)4 (57.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

DRIO

DarioHealth Corp.

Director

INDP

Indaptus Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

DRIO
DarioHealth Corp.
Sep 24, 2026
Award(A)
Direct
28K shares-
DRIO
DarioHealth Corp.
Sep 11, 2025
Award(A)
Direct
20K shares-
INDP
Indaptus Therapeutics, Inc.
Jun 10, 2025
Award(A)
Stock Option (right to buy)
Direct
12.5K shares-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
250 shares at avg. $0.39-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
500 shares at avg. $0.39-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
250 shares at avg. $0.39-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
281 shares at avg. $0.39-

		Type	Shares	Price		Ownership
Sep 24, 2026	DRIO DarioHealth Corp.	Award(A)	28,000	-	$0	Direct
Sep 11, 2025	DRIO DarioHealth Corp.	Award(A)	20,000	-	-	Direct
Jun 10, 2025	INDP Indaptus Therapeutics, Inc.	Award(A) Stock Option (right to buy)	12,500	-	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	250	$0.39	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	500	$0.39	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	250	$0.39	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	281	$0.39	-	Direct

1-7 of 7 transactions

About Karah Hila

Karah Hila (SEC CIK 0001668116) files insider reports with the SEC as Director of DarioHealth Corp. (DRIO) and Director of Indaptus Therapeutics, Inc. (INDP).

Signal8 holds 4 ownership filings by Karah Hila, all Form 4s, filed between Apr 11, 2025 and Sep 28, 2026. Those filings report 7 transactions, from Apr 10, 2025 to Sep 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Karah Hila's filings is in NEW YORK, NY.

Recent filings by Karah Hila

Sep 24, 2026: Grant or award of DRIO shares (Form 4, code A).
Sep 11, 2025: Grant or award of DRIO shares (Form 4, code A).
Jun 10, 2025: Grant or award of INDP derivative securities (Form 4, code A).
Apr 10, 2025: Disposition to issuer transactions of INDP derivative securities (4 lines, Form 4, code D).

Other insiders filing for DarioHealth Corp. (DRIO)

PALUMBO JOHN R, Director
STERN ADAM K, Director
MCGRATH DENNIS M, Director
Shaked Yoav, Director
Franco-Yehuda Chen, Chief Financial Officer
Matheis Dennis, Director

How to read Form 4 transaction codes